PRESS RELEASE published on 10/29/2024 at 11:46, 1 year 7 months ago Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF published on 10/28/2024 at 12:31, 1 year 7 months ago Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
BRIEF published on 10/28/2024 at 12:31, 1 year 7 months ago Ken Herrmann, expert en médecine nucléaire, rejoint le conseil d'administration de Pentixapharm Conseil De Surveillance Produits Radiopharmaceutiques Médecine Nucléaire Ken Herrmann Pipeline En Oncologie
PRESS RELEASE published on 10/28/2024 at 12:26, 1 year 7 months ago Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
BRIEF published on 10/25/2024 at 16:05, 1 year 7 months ago Pentixapharm Holding AG Announces Leadership Changes Leadership Changes Supervisory Board Pentixapharm Dr. Hakim Bouterfa Dr. Dirk Pleimes
BRIEF published on 10/25/2024 at 16:05, 1 year 7 months ago Pentixapharm Holding AG annonce des changements au sein de sa direction Conseil De Surveillance Changements De Direction Pentixapharm Docteur Hakim Bouterfa Dr Dirk Pleimes
PRESS RELEASE published on 10/25/2024 at 16:00, 1 year 7 months ago Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group Pentixapharm Holding AG announces upcoming changes in management and supervisory boards, including CEO transition and new board appointments CEO Transition Supervisory Board Management Changes Pentixapharm Holding AG Nuclear Medicine Specialist
BRIEF published on 10/19/2024 at 12:33, 1 year 8 months ago Pentixapharm's CXCR4 Compound Showcased at EANM Conference Radiopharmaceuticals Pentixapharm CXCR4 Targeting EANM Conference Theranostic Development
BRIEF published on 10/19/2024 at 12:33, 1 year 8 months ago Le composé CXCR4 de Pentixapharm présenté à la conférence EANM Produits Radiopharmaceutiques Pentixapharm Ciblage CXCR4 Conférence EANM Développement Théranostique
PRESS RELEASE published on 10/19/2024 at 12:28, 1 year 8 months ago Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM) Pentixapharm presents CXCR4 targeting compounds in 17 abstracts at EANM Congress, showcasing theranostic developments and research initiatives in various medical areas Radiopharmaceuticals Pentixapharm Theranostic Development CXCR4 EANM Congress
Published on 06/25/2026 at 09:05, 21 minutes ago Nano One and Worley Chemetics Complete One-Pot(TM) LFP Cathode Package and Advance to Market
Published on 06/25/2026 at 00:30, 8 hours 56 minutes ago Northern Dynasty Reports Annual General Meeting Results and Welcomes New Directors
Published on 06/24/2026 at 23:05, 10 hours 21 minutes ago Polaris Modifies Quorum Requirement for Upcoming AGM
Published on 06/24/2026 at 22:15, 11 hours 11 minutes ago Organto Foods Announces Annual General Meeting Results
Published on 06/24/2026 at 21:20, 12 hours 6 minutes ago Taranis to Explore New Properties East of Thor Mineral Resource
Published on 06/25/2026 at 09:00, 25 minutes ago OHB and Rheinmetall bring together Germany’s space ecosystem for SATCOMBw 4
Published on 06/25/2026 at 09:00, 26 minutes ago Novem Group S.A. confirms preliminary results for FY 2025/26
Published on 06/25/2026 at 09:00, 26 minutes ago LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships
Published on 06/25/2026 at 07:30, 1 hour 56 minutes ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
Published on 06/25/2026 at 07:30, 1 hour 56 minutes ago Gimv ondertekent een overeenkomst voor de overname van Groupe Cap Vert, de Franse marktleider in multispecialistische essentiële diensten voor het beheer van bomen en groene infrastructuur, van Ambienta.
Published on 06/25/2026 at 07:30, 1 hour 56 minutes ago Gimv signe un accord en vue d’acquérir le Groupe Cap Vert, leader français multi-spécialiste des services de gestion du patrimoine arboré et végétal, auprès d’Ambienta
Published on 06/24/2026 at 19:00, 14 hours 26 minutes ago ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %